Event
Women’s Life Sciences Network – Biotech Act: Funding and Investment Opportunities
Tuesday, May 19, 2026

Join us in Brussels for our next Women’s Life Sciences Network event on the occasion of the EU Pharmaceutical Law Forum.
Our speakers will discuss the proposed Biotech Act I, focusing on funding and regulatory support opportunities for the European biopharmaceutical industry.
Join our moderated panel discussion with:
- Felicitas Riedl, Director of Innovation and Competitiveness Department, European Investment Bank
- Alexandra Eftimie, Legal and Policy Officer, European Commission
- Kristin Thompson, Director, Merieux Equity Partner
- Valerie Vanhooren, CEO & Co-founder, Ona Therapeutics
The event will include a video address by Stine Bosse, MEP for the Renew Europe group and Vice Chair of the Committee on Public Health in the European Parliament.
Agenda
- Welcome and registration – 5:30 p.m. CEST
- Panel discussion and Q&A – 6:00 p.m. CEST
- Networking reception and canapés – 7:30 p.m. CEST
Stay tuned for more details. All are invited to attend WLSN events.
関連リソース
得意分野
Suggested News & Insights
GMP 2026: Regulatory Reliance, AI, and the Future of Pharmaceutical ManufacturingWednesday, December 2, 2026A New World Order – Market Access, MFN, and GeopoliticsTuesday, November 10, 2026Sidley & Trinity Capital Life Sciences ReceptionThursday, October 22, 2026A More Competitive MedTech Landscape in the EU? What the MDR/IVDR Revision Could Mean for MedTech Manufacturers and InvestorsOctober 16, 2026Sidley Ranked in Chambers UK 2027October 15, 2026California Adopts Regulations Expanding Healthcare Transaction ReviewOctober 8, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory